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Methods
• Baseline scan: Male 2 mo C57BL/6J mice were dark-adapted 
overnight and then light-adapted for 5 hours before undergoing short-
term ketamine / xylazine anesthesia for OCT examination; all mice fully 
recovered. 
• Drug scan: The next day, mice were similarly dark-adapted and again 5 
hour light-adapted. They were injected IP with either a clinically-viable 
dose of DNP (0.5 mg/kg, PMID: 30909602) 1 hour before OCT 
examination or equal volume of saline vehicle (control).
• Retinal laminae thicknesses were obtained using in-house software with 
particular attention to the external limiting membrane-retinal pigment 
epithelium (ELM-RPE) region, which becomes thinner at higher doses of 
DNP-provoked mitochondrial respiration (Figure 2, PMID: 31923239).
Purpose
• Devastating neurodegenerative diseases often involves dysfunctional 
mitochondrial respiration.
• Conventional imaging approaches are unable to measure mitochondrial 
respiration in vivo preventing early diagnosis and intervention to mitigate 
disease.
• Previously, we showed that a common clinical imaging method, optical 
coherence tomography (OCT) can measure mitochondrial respiration 
using an uncoupler 2,4 dinitrophenol (DNP, Figure 1) at a non-toxic but 
higher than clinically indicated doses (PMID: 31923239, 30909602).
• Here we test if OCT has the detection sensitivity to measure 
mitochondrial respiration using a dose of DNP that could be used in 
patients (PMID: 30909602). 
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Figure 1: DNP MOA. Schematic showing how DNP (red) reduces the 
proton gradient across the mitochondrial membrane. This results in 
increased mitochondrial respriation. Image from Bender, David. 
Overheating after Overdosing on E - and Slimming by Taking 
Dinitrophenol, david-
bender.co.uk/metabonline/energy/ATP/ATP21.html.
Figure 3: 1 hour post 0.5 
mg/kg DNP. Modelled change 
in ELM-RPE thickness from 
before (pre) and after (post) 
DNP or saline. As expected, 
saline produced no change in 
ELM-RPE thickness from zero 
(dashed line). In contrast, DNP 
caused a significant (p < 0.05) 
thinning of the ELM-RPE region 
(red star). N = 5-6 per group. 
Error bars: confidence intervals.
Figure 2: Working model. Left: Regions-of-interest are shown on a representative mouse 
OCT. INL: inner nuclear layer; including outer plexiform layer; ONL: outer nuclear layer; WR: 
whole retinal. Superior retina indicated. Right: A larger ELM-RPE region in the light can be 
converted to a smaller dark phenotype in the light in vivo by increasing mitochondrial 
respiration with DNP, based on this signaling pathway (PMID: 31923239).
Figure 4: 1 hour post 0.5 mg/kg DNP, other laminae. Data of two other laminae. Left
column: Comparison of before and after saline (purple) injection; right column: 
comparison of before and after DNP (green) injection. Error bars: SEM. No changes in 
other retinal laminae are evident with DNP within or between groups.
Conclusion
• The results of this study demonstrate for the first time in vivo that 
increase of mitochondrial respiration through administration of 
clinical doses of DNP can be detected with a clinical tool: OCT.
• Application of our novel approach is expected to transform 
management of mitochondrial-based, sight-threatening diseases, 
and potentially other neurodegenerative disease.
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